/

Other

/

Everest Medicines

Everest Medicines

Everest Medicines

Verified Nov 2026

Other

·

United States flag

New York, New York

·

Since 2017

Everest Medicines is a biopharmaceutical company founded in 2017 and headquartered in Shanghai, China, with 500–1,000 employees and estimated revenue of $100–250 million. The company discovers, develops, manufactures, and commercializes therapeutic products and vaccines for renal diseases, infectious diseases, immunology, and oncology, primarily serving Greater China and Asia-Pacific markets with plans for global expansion. It operates a commercial-scale manufacturing facility in Jiashan, China, and maintains an approved product portfolio including Nefecon for IgA Nephropathy and Velsipity for autoimmune disorders.

Everest Medicines

Verified Nov 2026

AT A GLANCE

Founded

2017

Headquarters

United States flag

New York, New York

Employees

500-1,000

Ownership

Everest Medicines at a glance

Revenue

$100-250M

Est. band

Employees

500-1,000

Founded

2017

Headquarters

New York, New York

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Everest Medicines is a biopharmaceutical company founded in 2017 and headquartered in Shanghai, China, with 500–1,000 employees and estimated revenue of $100–250 million. The company discovers, develops, manufactures, and commercializes therapeutic products and vaccines for renal diseases, infectious diseases, immunology, and oncology, primarily serving Greater China and Asia-Pacific markets with plans for global expansion. It operates a commercial-scale manufacturing facility in Jiashan, China, and maintains an approved product portfolio including Nefecon for IgA Nephropathy and Velsipity for autoimmune disorders.

At a glance

Attribute

Detail

Founded

2017

Headquarters

New York, New York

Employees

500-1,000

Revenue

$100-250M (estimated)

What Everest Medicines makes

The company operates a commercial-scale manufacturing facility and maintains a portfolio of 11 drug candidates, many in late-stage clinical development across renal, infectious, immunological, and oncology indications.

Latest developments

Facilities

Everest Medicines is headquartered in New York, New York. Public sources also reference these locations:

Company details

Everest Medicines has executed multiple licensing and acquisition agreements in 2026, including exclusive licensing for Civorebrutinib from Travere Therapeutics and an asset purchase agreement for Etripamil nasal spray development in Greater China. Everest Medicines was founded in 2017, has an estimated 500-1,000 employees, and is headquartered in New York, New York.

Frequently asked questions

What does Everest Medicines do?

Everest Medicines is a biopharmaceutical company founded in 2017 and headquartered in Shanghai, China, with 500–1,000 employees and estimated revenue of $100–250 million. The company discovers, develops, manufactures, and commercializes therapeutic products and vaccines for renal diseases, infectious diseases, immunology, and oncology, primarily serving Greater China and Asia-Pacific markets with plans for global expansion. It operates a commercial-scale manufacturing facility in Jiashan, China, and maintains an approved product portfolio including Nefecon for IgA Nephropathy and Velsipity for autoimmune disorders.

Where is Everest Medicines headquartered?

Everest Medicines is headquartered in New York, New York (450 Lexington Avenue, New York, New York, 10017).

When was Everest Medicines founded?

Everest Medicines was founded in 2017.

How big is Everest Medicines?

Everest Medicines has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

New York, New York (HQ)Headquarters · United States
New York, New York (HQ)450 Lexington Avenue, New York, New York, 10017, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.